Also, in January 2006 we completed the sale to Indevus
Pharmaceuticals, Inc. (Indevus) of Delatestryl, our
former injectable testosterone product for male hypogonadism.
Under the terms of the sale, Indevus paid us an initial payment
of $5 million and a portion of net sales of the product for
the first three years following closing of the transaction based
on an escalating scale.
QUOTE
As of 12:44PM EDT May 25, 2012
$ ()
Today's Open:Today's Close:
Today's High:
Volume (thous):
Today's Low:
Avg Vol (thous):
52 Week High:
Bid (size):
52 Week Low:
Ask (size):
COMPANY INFO
To see the headquarters in Google Street View &trade, drag this yellow guy: over to the red pointer:
Contact Information:
Business Address:
-
Mailing Address:
ONE TOWER CENTER
EAST BRUNSWICK NJ 08816
Business Address
ONE TOWER CENTER
EAST BRUNSWICK NJ 08816
7324189300
SAVIENT PHARMACEUTICALS INC CIK #: 00